Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2019
March 06, 2019 06:30 ET
|
Avivagen Inc.
OTTAWA, March 06, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”) reported today its unaudited financial results for Q1 2019. For the three-month period ended...
Avivagen Announces Large Order for OxC-beta™ Livestock and Expansion into Additional Applications
February 28, 2019 06:30 ET
|
Avivagen Inc.
OTTAWA, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that its partner in the Philippines, UNAHCO, has purchased 2 metric tons of OxC-beta™...
Avivagen enters into Partnership with CSA to Sell and Distribute OxC-beta™ Livestock in the United States
February 20, 2019 06:30 ET
|
Avivagen Inc.
OTTAWA, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that it has signed a partnership with CSA Animal Nutrition providing for the sales and...
Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2018
January 31, 2019 16:30 ET
|
Avivagen Inc.
OTTAWA, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) reported its audited financial results for the year ended October 31, 2018. Unless otherwise noted, all figures are in...
Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants
January 18, 2019 06:30 ET
|
Avivagen Inc.
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. OTTAWA, Jan. 18, 2019 ...
Avivagen Announces CEO Letter to Shareholders
January 17, 2019 06:30 ET
|
Avivagen Inc.
OTTAWA, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce its 2019 letter to shareholders by Chairman and interim CEO Kym Anthony. To our shareholders: ...
Avivagen Inc. Announces Change of Auditor
January 03, 2019 17:00 ET
|
Avivagen Inc.
OTTAWA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) announces the appointment of UHY McGovern Hurley LLP as auditors. UHY McGovern Hurley LLP has been appointed to carry...
Avivagen Announces Proposed Extension of Warrants
December 20, 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or “Corporation”), a world leader in natural alternatives to antibiotics with its OxC-beta™ technology, today announced...
Avivagen Announces Clarification to Press Release Issued November 19, 2018
November 19, 2018 19:20 ET
|
Avivagen Inc.
OTTAWA, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”), announces a clarification to its press release issued Monday, November 19th at 6:30 A.M. EST. The previous NR had...
Avivagen’s Asian partner UNAHCO continues to ramp-up use of OxC-beta™ Livestock with new large order
November 19, 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”), is pleased to announce that its partner in the Philippines, UNAHCO, has purchased 2 metric tonnes of OxC-beta™...